Mechanistic insights and clinical implications of cross-reactive anti-prophage antibodies and bacterial heteroresistance on phage therapeutic failure
Fernando Gordillo Altamirano(Monash University), Anton Y. Peleg(Australian Regenerative Medicine Institute), Jeremy J. Barr(San Diego State University), Denis Korneev(State Research Center of Virology and Biotechnology VECTOR), Jessica A. Wisniewski(The Alfred Hospital), Katherine Pragastis(The Alfred Hospital), D. Keating(Alfred Health), Bradley J. Gardiner(Austin Health), Devang Patel(Monash University), Catherine Rees(Melbourne Water), Yael Hammerschlag(Alfred Health), Sofia Dahlman(Monash University), Hayley S. Ramshaw(South Australia Pathology), Matthew H. Parker(Monash University), Dinesh Subedi(Monash University), Michael J Bucher(University of Chicago), Tom Kotsimbos(Alfred Health), Sadid F Khan(Alfred Health), Mariel Beiers(Monash University), Jane Hawkey(The University of Melbourne)
Cited by 1
Related Papers
Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events
|Nature Genetics|2015|489
The Mechanisms of Disease Caused by Acinetobacter baumannii
|Frontiers in Microbiology|2019|360
Multidrug-resistant Gram-negative bacterial infections
|The Lancet|2025|223
Pulmonary vascular endothelium: the orchestra conductor in respiratory diseases
|European Respiratory Journal|2018|214